- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 04-12-2025: Press Release
04-12-2025 | 12:45 pm
04-12-2025 | 12:45 pm
Zydus received a USFDA Establishment Inspection Report (EIR) for its Jarod injectable facility, classifying it as Voluntary Action Indicated (VAI). This positive development follows a prior Warning Letter, signaling progress on regulatory compliance.
No comments yet. Be the first to comment!